Meta-Analysis of Adherence Promotion Interventions in Pediatric Asthma

Andrea Fidler1, Rachel Sweenie1, Adrian Ortega2

  • 1Department of Clinical & Health Psychology, University of Florida.

Insights

Interventions effectively improve inhaled corticosteroid (ICS) adherence in pediatric asthma patients. Further research is needed to understand long-term effectiveness and identify optimal strategies for promoting ICS adherence.

Area of Science:

  • Pediatric Pulmonology
  • Behavioral Science
  • Health Services Research

Background:

  • Suboptimal adherence to inhaled corticosteroids (ICS) is common in youth with asthma.
  • Systematic evaluation of ICS adherence promotion interventions is critical for identifying effective strategies.

Purpose of the Study:

  • Quantify the effectiveness of interventions on ICS adherence in pediatric asthma.
  • Explore how intervention and study characteristics influence effect sizes.
  • Characterize the risk of bias in these interventions.

Main Methods:

  • Conducted literature searches across five databases for studies published after 1997.
  • Included studies quantitatively measured ICS adherence in youth (<18 years) with asthma.
  • Analyzed aggregate effect sizes and moderator variables using random-effects models and assessed risk of bias with the Cochrane Collaboration tool.

Main Results:

  • Thirty-three studies showed a small but significant aggregate effect size for ICS adherence promotion interventions post-intervention (g=0.39).
  • Effect size at follow-up was not statistically significant (g=0.38).
  • Intervention format and adherence measurement method were significant moderators; most interventions had high performance bias risk.

Conclusions:

  • ICS adherence promotion interventions demonstrate effectiveness in youth with asthma.
  • Longitudinal research is needed for precise long-term effectiveness measures.
  • Reassessment of moderators is recommended as the literature expands.
Abstract

Related Concept Videos

Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.4K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
863
Antiasthma Drugs: &#946;2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
672
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
735
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.7K